Daytime Bright Light, Circadian Abnormalities, and Delirium in Medical ICU Patients

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions
Circadian Rhythm Disorders
Interventions
DEVICE

Daytime Bright Light

Daytime Bright Light (DBL) will be delivered by a free-standing apparatus set to deliver 10,000 lux. The device will be placed at the bedside within 36 inches of the patient's head and is expected to provide at least 1,250 lux at the angle of gaze. To remain in the study, the patient must be in the Intensive Care Unit (ICU) through 13:00 on day 2 (e.g., the first day of potential intervention). After day 2, DBL and other study activities will continue if the patient is transferred out of the ICU to the general medical floor.

DEVICE

Usual Light

"Usual care lighting in ICU.~To remain in the study usual care patients must also remain in the MICU through 13:00 on day 2."

Trial Locations (1)

06520

Yale New Haven Hospital, York Street Campus, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT03684460 - Daytime Bright Light, Circadian Abnormalities, and Delirium in Medical ICU Patients | Biotech Hunter | Biotech Hunter